Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bioshares Biotech Clinical Trial (BBC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BioShares
  • Assets Under Management 30,145,500
  • Market Capitalization, $K 30,146
  • Shares Outstanding, K 1,050
  • 60-Month Beta 1.97
  • Price/Book 3.38
  • Price/Earnings ttm 27.17
  • Annual Dividend & Yield 0.30 (1.05%)
  • Most Recent Dividend 0.297 on 12/20/17
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.61 +12.07%
on 02/22/19
28.81 -0.38%
on 03/19/19
+3.15 (+12.33%)
since 02/21/19
3-Month
20.22 +41.94%
on 12/24/18
28.81 -0.38%
on 03/19/19
+7.78 (+37.19%)
since 12/21/18
52-Week
20.22 +41.94%
on 12/24/18
35.86 -19.97%
on 08/31/18
-5.95 (-17.17%)
since 03/21/18

Most Recent Stories

More News
Trump Proposes 2020 Budget: ETFs to Top & Flop

Here are the key takeaways from the proposed 2020 budget and their expected impact on ETFs.

PPA : 58.08 (+0.78%)
BBC : 28.70 (+1.16%)
EWW : 45.03 (+0.20%)
PBW : 27.80 (-0.79%)
CNCR : 21.16 (-0.38%)
XAR : 92.29 (+1.02%)
GNRX : 22.53 (+2.48%)
MOO : 62.72 (+0.55%)
BTEC : 35.63 (+0.54%)
QCLN : 20.61 (+0.11%)
ITA : 199.03 (+0.74%)
CARZ : 33.39 (-0.83%)
IEIH : 25.80 (-1.49%)
XLP : 54.96 (+0.83%)
Trump Proposes 2020 Budget: ETFs to Top & Flop

Here are the key takeaways from the proposed 2020 budget and their expected impact on ETFs.

PPA : 58.08 (+0.78%)
BBC : 28.70 (+1.16%)
EWW : 45.03 (+0.20%)
PBW : 27.80 (-0.79%)
CNCR : 21.16 (-0.38%)
XAR : 92.29 (+1.02%)
GNRX : 22.53 (+2.48%)
MOO : 62.72 (+0.55%)
BTEC : 35.63 (+0.54%)
QCLN : 20.61 (+0.11%)
ITA : 199.03 (+0.74%)
CARZ : 33.39 (-0.83%)
IEIH : 25.80 (-1.49%)
XLP : 54.96 (+0.83%)
6 Wining ETF Areas From a Late Santa Rally

These sector ETFs have made the most of the start of this Santa Rally.

PSCE : 11.16 (+1.09%)
BNO : 19.36 (unch)
BBC : 28.70 (+1.16%)
ARKW : 52.48 (+0.96%)
PTH : 82.45 (+1.59%)
IYW : 193.32 (+1.42%)
PRN : 60.77 (+0.90%)
IGM : 208.67 (+1.30%)
USO : 12.50 (+0.16%)
IEO : 59.24 (+0.65%)
SBIO : 36.39 (+1.34%)
JETS : 28.91 (+0.07%)
IGV : 212.55 (+1.38%)
XBI : 91.47 (+1.26%)
IBUY : 49.76 (+0.18%)
6 Wining ETF Areas From a Late Santa Rally

These sector ETFs have made the most of the start of this Santa Rally.

PSCE : 11.16 (+1.09%)
BNO : 19.36 (unch)
BBC : 28.70 (+1.16%)
ARKW : 52.48 (+0.96%)
PTH : 82.45 (+1.59%)
IYW : 193.32 (+1.42%)
PRN : 60.77 (+0.90%)
IGM : 208.67 (+1.30%)
USO : 12.50 (+0.16%)
IEO : 59.24 (+0.65%)
SBIO : 36.39 (+1.34%)
JETS : 28.91 (+0.07%)
IGV : 212.55 (+1.38%)
XBI : 91.47 (+1.26%)
IBUY : 49.76 (+0.18%)
4 Worst ETF Areas of Q4

These ETF areas have been particularly painful in the bloodbath of the fourth quarter.

PSCE : 11.16 (+1.09%)
USO : 12.50 (+0.16%)
BBC : 28.70 (+1.16%)
PXJ : 7.28 (-0.41%)
XES : 11.96 (+0.50%)
MJ : 38.22 (-0.39%)
FNG : 16.50 (+0.49%)
OIH : 17.77 (+0.11%)
4 Worst ETF Areas of Q4

These ETF areas have been particularly painful in the bloodbath of the fourth quarter.

PSCE : 11.16 (+1.09%)
USO : 12.50 (+0.16%)
BBC : 28.70 (+1.16%)
PXJ : 7.28 (-0.41%)
XES : 11.96 (+0.50%)
MJ : 38.22 (-0.39%)
FNG : 16.50 (+0.49%)
OIH : 17.77 (+0.11%)
Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?

Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.

BBC : 28.70 (+1.16%)
XHS : 66.80 (+0.93%)
PTH : 82.45 (+1.59%)
JNJ : 138.26 (+0.71%)
HCA : 136.53 (+1.07%)
CNC : 58.72 (+0.07%)
CYS : 7.31 (-1.08%)
PSCH : 119.30 (+1.55%)
UNH : 251.84 (+0.53%)
THC : 30.64 (+3.44%)
Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?

Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.

BBC : 28.70 (+1.16%)
XHS : 66.80 (+0.93%)
PTH : 82.45 (+1.59%)
JNJ : 138.26 (+0.71%)
HCA : 136.53 (+1.07%)
CNC : 58.72 (+0.07%)
CYS : 7.31 (-1.08%)
PSCH : 119.30 (+1.55%)
UNH : 251.84 (+0.53%)
THC : 30.64 (+3.44%)
Top and Flop ETFs at Half-Way Q4

We have highlighted both the best and worst performing zones and their ETFs at halfway Q4.

BBC : 28.70 (+1.16%)
PUI : 32.27 (+0.97%)
FFTY : 33.57 (+1.57%)
RING : 17.74 (-0.34%)
EWZS : 15.75 (-3.61%)
VIXY : 23.85 (-0.50%)
MJ : 38.22 (-0.39%)
OIH : 17.77 (+0.11%)
Top and Flop ETFs at Half-Way Q4

We have highlighted both the best and worst performing zones and their ETFs at halfway Q4.

BBC : 28.70 (+1.16%)
PUI : 32.27 (+0.97%)
FFTY : 33.57 (+1.57%)
RING : 17.74 (-0.34%)
EWZS : 15.75 (-3.61%)
VIXY : 23.85 (-0.50%)
MJ : 38.22 (-0.39%)
OIH : 17.77 (+0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade BBC with:

Fund Summary

The BioShares Biotechnology Clinical Trials Fund seeks investment results that correspond to the performance of the BioShares Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their...

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 28.92
1st Resistance Point 28.64
Last Price 28.70
1st Support Level 28.23
2nd Support Level 28.09

See More

52-Week High 35.86
Fibonacci 61.8% 29.89
Last Price 28.70
Fibonacci 50% 28.04
Fibonacci 38.2% 26.19
52-Week Low 20.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar